Cox-2 gene polymorphism and IL-6 levels in coronary artery disease

被引:16
作者
Ol, K. K. [2 ]
Agachan, B. [2 ]
Gormus, U. [3 ]
Toptas, B. [2 ]
Isbir, T. [1 ]
机构
[1] Yeditepe Univ, Fac Med, Dept Med Biol, Istanbul, Turkey
[2] Istanbul Univ, Inst Expt Med, Dept Mol Med, Istanbul, Turkey
[3] Istanbul Bilim Univ, Fac Med, Dept Biochem, Istanbul, Turkey
关键词
Cox-2 (-765G > C); Polymorphism; Diabetes mellitus; Coronary artery disease; IL-6; CYCLOOXYGENASE-2; RISK; SYNTHASE; ATHEROTHROMBOSIS; ATHEROSCLEROSIS; INFLAMMATION; EXPRESSION;
D O I
10.4238/vol10-2gmr967
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Coronary artery disease is one of the leading causes of mortality and diabetes mellitus is one of its main risk factors due to microvascular and macrovascular complications, such as atherosclerosis. Atherosclerosis is now known to be an inflammatory process mediated by prostaglandins and several interleukins. As both are important in inflammatory processes, we examined Cox-2 (-765G > C) polymorphism and interleukin-6 levels in coronary artery disease patients compared to healthy controls. We also divided the patients into diabetic and nondiabetic groups to check the effects of diabetes mellitus separately. We found that the GG allele frequency was significantly higher in the patient group. Patients with the GG genotype had an approximately 2.78-fold higher risk of coronary artery disease. We also found that the Cox-2 (-765G > C) polymorphism is associated with lower interleukin-6 levels, which decreased in the order: GG > GC > CC.
引用
收藏
页码:810 / 816
页数:7
相关论文
共 24 条
[1]   Cyclooxygenase inhibition and cardiovascular risk [J].
Antman, EM ;
DeMets, D ;
Loscalzo, J .
CIRCULATION, 2005, 112 (05) :759-770
[2]   WHY IS DIABETES-MELLITUS A STRONGER RISK FACTOR FOR FATAL ISCHEMIC-HEART-DISEASE IN WOMEN THAN IN MEN - THE RANCHO-BERNARDO STUDY [J].
BARRETTCONNOR, EL ;
COHN, BA ;
WINGARD, DL ;
EDELSTEIN, SL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (05) :627-631
[3]  
Belton O, 2000, CIRCULATION, V102, P840
[4]   Atherothrombosis, inflammation, and diabetes [J].
Biondi-Zoccai, GGL ;
Abbate, A ;
Liuzzo, G ;
Biasucci, LM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (07) :1071-1077
[5]   Suppression of the functionally coupled cyclooxygenase-2/prostaglandin E synthase as a basis of simvastatin-dependent plaque stabilization in humans [J].
Cipollone, F ;
Fazia, M ;
Iezzi, A ;
Zucchelli, M ;
Pini, B ;
De Cesare, D ;
Ucchino, S ;
Spigonardo, F ;
Bajocchi, G ;
Bei, R ;
Muraro, R ;
Artese, L ;
Piattelli, A ;
Chiarelli, F ;
Cuccurullo, F ;
Mezzetti, A .
CIRCULATION, 2003, 107 (11) :1479-1485
[6]   Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E2-dependent plaque instability [J].
Cipollone, F ;
Prontera, C ;
Pini, B ;
Marini, M ;
Fazia, M ;
De Cesare, D ;
Iezzi, A ;
Ucchino, S ;
Boccoli, G ;
Saba, V ;
Chiarelli, F ;
Cuccurullo, F ;
Mezzetti, A .
CIRCULATION, 2001, 104 (08) :921-927
[7]  
Davis SN., 2006, Insulin, Oral Hypoglycemic Agents, and the Pharmacology of the Endocrine Pancreas, VEleventh
[8]  
Gavin JR, 1997, DIABETES CARE, V20, P1183
[9]   Inducible cyclooxygenase may have anti-inflammatory properties [J].
Gilroy, DW ;
Colville-Nash, PR ;
Willis, D ;
Chivers, J ;
Paul-Clark, MJ ;
Willoughby, DA .
NATURE MEDICINE, 1999, 5 (06) :698-701
[10]   Polymorphisms of prostaglandin-endoperoxide synthase 2 gene, and prostaglandin-E receptor 2 gene, C-reactive protein concentrations and risk of atherothrombosis: a nested case-control approach [J].
Hegener, H. H. ;
Diehl, K. A. ;
Kurth, T. ;
Gaziano, J. M. ;
Ridker, P. M. ;
Zee, R. Y. L. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (08) :1718-1722